Glycolysis is preferred in breast CD44+CD24lowEPCAM+ CSCs, sphere-forming radio-resistant nasopharyngeal carcinoma cells (42) and CD133+CD49f+ tumor initiating cells (TICs) in hepatocellular carcinoma (43). This evidence concerns the gene PROM1 and hepatocellular carcinoma.